SG11202105730TA - Benzamides of pyrazolyl-amino-pyrimidinyl derivatives, and compositions and methods thereof - Google Patents
Benzamides of pyrazolyl-amino-pyrimidinyl derivatives, and compositions and methods thereofInfo
- Publication number
- SG11202105730TA SG11202105730TA SG11202105730TA SG11202105730TA SG11202105730TA SG 11202105730T A SG11202105730T A SG 11202105730TA SG 11202105730T A SG11202105730T A SG 11202105730TA SG 11202105730T A SG11202105730T A SG 11202105730TA SG 11202105730T A SG11202105730T A SG 11202105730TA
- Authority
- SG
- Singapore
- Prior art keywords
- benzamides
- pyrazolyl
- amino
- compositions
- methods
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/08—Bridged systems
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CN2018/121165 WO2020118683A1 (en) | 2018-12-14 | 2018-12-14 | Benzamides of pyrazolyl-amino-pyrimidinyl derivatives, and compositions and methods thereof |
PCT/CN2019/125552 WO2020119819A1 (en) | 2018-12-14 | 2019-12-16 | Benzamides of pyrazolyl-amino-pyrimidinyl derivatives, and compositions and methods thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202105730TA true SG11202105730TA (en) | 2021-06-29 |
Family
ID=71076270
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202105730TA SG11202105730TA (en) | 2018-12-14 | 2019-12-16 | Benzamides of pyrazolyl-amino-pyrimidinyl derivatives, and compositions and methods thereof |
Country Status (14)
Country | Link |
---|---|
US (4) | US20220298144A1 (pt) |
EP (1) | EP3877381A4 (pt) |
JP (1) | JP7459094B2 (pt) |
KR (1) | KR20210125983A (pt) |
CN (1) | CN113227074A (pt) |
AU (3) | AU2019399939A1 (pt) |
BR (1) | BR112021011147A2 (pt) |
CA (3) | CA3122872A1 (pt) |
EA (1) | EA202191188A1 (pt) |
IL (1) | IL283968A (pt) |
MX (1) | MX2021006866A (pt) |
SG (1) | SG11202105730TA (pt) |
TW (1) | TW202039474A (pt) |
WO (2) | WO2020118683A1 (pt) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110627775A (zh) | 2019-10-24 | 2019-12-31 | 嘉兴特科罗生物科技有限公司 | 一种小分子化合物 |
WO2021204159A1 (en) | 2020-04-08 | 2021-10-14 | Agios Pharmaceuticals, Inc. | Menin inhibitors and methods of use for treating cancer |
CN112661655B (zh) * | 2020-12-29 | 2022-02-18 | 江苏云朴医药新材料科技有限公司 | 一种1-氨甲基-1-环丙醇类化合物及其合成方法 |
WO2024041397A1 (en) * | 2022-08-22 | 2024-02-29 | Hangzhou Highlightll Pharmaceutical Co., Ltd | Jak1/jak2/tyk2 inhibitors for topical treatment of dermatological diseases |
WO2023151724A1 (zh) * | 2023-05-19 | 2023-08-17 | 凌科药业(杭州)有限公司 | 一种吡唑基-氨基-嘧啶基衍生物的晶型、制备方法及应用 |
CN116983312A (zh) * | 2023-05-24 | 2023-11-03 | 凌科药业(杭州)有限公司 | 一种药物组合物、外用制剂及其制备方法、应用 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009017838A2 (en) * | 2007-08-01 | 2009-02-05 | Exelixis, Inc. | Combinations of jak-2 inhibitors and other agents |
MY152948A (en) * | 2007-11-16 | 2014-12-15 | Incyte Corp | 4-pyrazolyl-n-arylpyrimidin-2-amines and 4-pyrazolyl-n-heteroarylpyrimidin-2-amines as janus kinase inhibitors |
EP2638018A1 (en) * | 2010-11-09 | 2013-09-18 | Cellzome Limited | Pyridine compounds and aza analogues thereof as tyk2 inhibitors |
WO2012143320A1 (en) * | 2011-04-18 | 2012-10-26 | Cellzome Limited | (7h-pyrrolo[2,3-d]pyrimidin-2-yl)amine compounds as jak3 inhibitors |
EP2736901A1 (en) * | 2011-07-28 | 2014-06-04 | Cellzome Limited | Heterocyclyl pyrimidine analogues as jak inhibitors |
DE102011112978A1 (de) * | 2011-09-09 | 2013-03-14 | Merck Patent Gmbh | Benzonitrilderivate |
KR101361149B1 (ko) * | 2012-07-17 | 2014-02-24 | 전남대학교산학협력단 | 가뭄 스트레스 저항성 관련 유전자 및 형질전환 식물체 |
RS57662B1 (sr) * | 2013-12-11 | 2018-11-30 | Biogen Ma Inc | Biaril jedinjenja korisna za lečenje humanih bolesti u onkologiji, neurologiji i imunologiji |
CN106349224A (zh) * | 2016-08-03 | 2017-01-25 | 山东大学 | 一种含有4‑氨基‑(1h)‑吡唑结构的jak激酶抑制剂及其制备方法和应用 |
CN108864057B (zh) * | 2017-05-16 | 2020-03-31 | 山东大学 | 含有4-氨基吡唑结构的jak与hdac双靶点抑制剂及其制备方法和应用 |
WO2020206588A1 (en) * | 2019-04-08 | 2020-10-15 | Lynk Pharmaceuticals Co., Ltd. | Benzethers and anilines of pyrazolyl-amino-pyrimidinyl derivatives, and compositions and methods thereof |
CN110330484B (zh) * | 2019-07-18 | 2022-08-26 | 中国药科大学 | 取代类苯基嘧啶衍生物作为jak激酶抑制剂或其可药用的盐、制备方法及用途 |
CN110627775A (zh) * | 2019-10-24 | 2019-12-31 | 嘉兴特科罗生物科技有限公司 | 一种小分子化合物 |
-
2018
- 2018-12-14 WO PCT/CN2018/121165 patent/WO2020118683A1/en active Application Filing
-
2019
- 2019-12-13 TW TW108145807A patent/TW202039474A/zh unknown
- 2019-12-16 AU AU2019399939A patent/AU2019399939A1/en active Pending
- 2019-12-16 MX MX2021006866A patent/MX2021006866A/es unknown
- 2019-12-16 BR BR112021011147-6A patent/BR112021011147A2/pt unknown
- 2019-12-16 EA EA202191188A patent/EA202191188A1/ru unknown
- 2019-12-16 KR KR1020217019621A patent/KR20210125983A/ko active Search and Examination
- 2019-12-16 EP EP19896790.3A patent/EP3877381A4/en active Pending
- 2019-12-16 CN CN201980076141.2A patent/CN113227074A/zh active Pending
- 2019-12-16 CA CA3122872A patent/CA3122872A1/en active Pending
- 2019-12-16 SG SG11202105730TA patent/SG11202105730TA/en unknown
- 2019-12-16 WO PCT/CN2019/125552 patent/WO2020119819A1/en active Application Filing
- 2019-12-16 CA CA3230060A patent/CA3230060A1/en active Pending
- 2019-12-16 JP JP2021530299A patent/JP7459094B2/ja active Active
- 2019-12-16 CA CA3230071A patent/CA3230071A1/en active Pending
-
2021
- 2021-06-14 IL IL283968A patent/IL283968A/en unknown
-
2022
- 2022-03-01 US US17/684,164 patent/US20220298144A1/en active Pending
- 2022-03-01 US US17/684,030 patent/US20230002362A1/en active Pending
-
2023
- 2023-09-10 US US18/244,276 patent/US20240025882A1/en active Pending
- 2023-09-24 US US18/372,115 patent/US20240083881A1/en active Pending
-
2024
- 2024-02-21 AU AU2024201128A patent/AU2024201128A1/en active Pending
- 2024-02-21 AU AU2024201125A patent/AU2024201125A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
US20220298144A1 (en) | 2022-09-22 |
JP2022510925A (ja) | 2022-01-28 |
BR112021011147A2 (pt) | 2021-08-31 |
EA202191188A1 (ru) | 2021-11-29 |
IL283968A (en) | 2021-07-29 |
TW202039474A (zh) | 2020-11-01 |
CN113227074A (zh) | 2021-08-06 |
US20240025882A1 (en) | 2024-01-25 |
US20230416235A1 (en) | 2023-12-28 |
KR20210125983A (ko) | 2021-10-19 |
AU2019399939A1 (en) | 2021-06-24 |
MX2021006866A (es) | 2021-11-17 |
CA3122872A1 (en) | 2020-06-18 |
EP3877381A1 (en) | 2021-09-15 |
WO2020119819A1 (en) | 2020-06-18 |
US20230002362A1 (en) | 2023-01-05 |
US20240083881A1 (en) | 2024-03-14 |
EP3877381A4 (en) | 2022-08-24 |
CA3230071A1 (en) | 2020-06-18 |
JP7459094B2 (ja) | 2024-04-01 |
AU2024201125A1 (en) | 2024-03-14 |
AU2024201128A1 (en) | 2024-03-14 |
CA3230060A1 (en) | 2020-06-18 |
WO2020118683A1 (en) | 2020-06-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2582482B (en) | CASZ compositions and methods of use | |
IL280963A (en) | Anti-5gdf1 antibodies, compounds and methods of use | |
IL272367A (en) | Antibodies against CD39, compositions containing antibodies against CD39 and methods of using antibodies against CD39 | |
EP3576782A4 (en) | COMPOSITIONS OF RECOMBINATION PRODUCT-PEPTIDE AND THEIR METHODS OF USE | |
EP3313404A4 (en) | THERAPEUTIC COMPOSITIONS, ASSOCIATIONS AND METHODS OF USE | |
EP3595653A4 (en) | PLINABULIN COMPOSITIONS AND THEIR USE | |
GB2582100B (en) | CAS12C Compositions and methods of use | |
IL283968A (en) | Benzamides of pyrazole-amino-pyrimidine type substances and their use | |
EP3337823A4 (en) | SUPPORTING BIN COMPOSITIONS AND METHOD FOR THE PRODUCTION AND USE THEREOF | |
ZA202102034B (en) | Anti-hla-g antibodies, compositions comprising anti-hla-g antibodies and methods of using anti-hla-g antibodies | |
HK1259372A1 (zh) | 治療化合物、其組合物及使用方法 | |
IL244278A0 (en) | An ingredient containing cannabinoids, methods for its preparation and its uses | |
EP3691677A4 (en) | COMPOSITIONS OF SACCHARIDE-POLYPEPTIDE CONJUGATES AND THEIR METHODS OF USE | |
ZA201906169B (en) | Synthekine compositions and methods of use | |
ZA202100780B (en) | Bismuth-thiol compositions and methods of use | |
IL289763A (en) | Compounds, pharmaceutical compounds and methods for preparing compounds and their use | |
IL276135A (en) | Preparations and methods of use | |
IL282939A (en) | Mixtures and preparations containing 5-fluoro-4-imino-3-methyl-1-tosyl-4,3-dihydropyrimidin-2-one and methods of using them | |
SG11202011227VA (en) | Compositions comprising bisfluoroalkyl-1,4-benzodiazepinone compounds and methods of use thereof | |
IL287014A (en) | History of pyrazolyl-amino-pyrimidine, preparations containing them and their use | |
IL272834A (en) | Compositions of amantadine, their preparation, and methods of use | |
EP3773654C0 (en) | POLYPHARMACEUTICAL DRUG COMPOSITIONS AND ASSOCIATED METHODS | |
SG11202011041YA (en) | Combination compositions comprising bisfluoroalkyl-1,4- benzodiazepinone compounds and methods of use thereof | |
EP3367998A4 (en) | NOVEL METHOD OF USE AND COMPOSITIONS | |
IL269884B1 (en) | Gamkaban its accepted pharmaceutical salts, their compositions and methods of their use |